Market Capitalization

A Canadian biotech is developing a novel cancer drug. We look beyond the paid promotions to analyze the science, the strategy, and the high-stakes reality.

MicroAlgo unveils a quantum encryption algorithm using hyper-chaotic keys, promising near-unbreakable security for medical scans and financial documents.

Under CEO Wahid Nawabi, AeroVironment's value soared. We explore the strategy, technology, and personal mission driving this defense innovation leader.

Calgary-based Horizon Petroleum launches a private placement to advance its key Lachowice gas project, a strategic play in Europe's quest for energy security.

FMC's $114M sale-leaseback reflects a wider trend of monetizing real estate. We analyze the deal's impact on its debt, R&D, and what it signals for the market.

Hyperscale Data builds a $46M Bitcoin treasury while planning a 590MW AI data center empire, forcing a strategic split and raising investor questions.

The indefinite shutdown of a key Canadian refinery isn't just about one company's troubles; it's a stark warning of North America's fragile EV supply chain.

With a sub-$10M market cap and blockbuster data, IMUNON's CEO faces a critical test: convince Wall Street its ovarian cancer drug is the real deal.

With a key regulatory win, the American Water-Essential Utilities merger moves closer to creating a utility behemoth. What does this mean for customers?

A class-action lawsuit alleges the data firm inflated its outlook by obscuring how sales mix impacted its key ARR metric, sparking a 31% stock plunge.

Largest shareholder Jorey Chernett pressures SMHI's board, alleging operational failures and a valuation disconnect that could be worth billions to investors.

TerraVest Industries faces a governance crisis as its stock tumbles. Chairman Charles Pellerin is under scrutiny, sparking a class action investigation.

Intellicheck’s entry into the Russell 2000 validates its growth. But what does this mean for investors and the broader fight against digital identity fraud?

Veea Inc. bolsters its leadership to capture the booming edge AI market, but can seasoned executives overcome daunting financial hurdles and fierce competition?

With compelling Phase 2b survival data, NeuroSense is advancing its multi-target ALS drug to a pivotal Phase 3 trial. A deep dive into the science and strategy.

Nextpower's acquisition of Zimmermann PV-Steel is more than a line item. It's a calculated move to dominate Europe's specialized solar market.

Nokia's lunar tech unit is spinning off into Modul8 Corp. With C$56.7M in funding and a board including Chris Hadfield, it's a new powerhouse in space.

The global market for warehouse automation is set to double, but the path to an intelligent supply chain is fraught with challenges. Here's what's driving it.

With a seasoned regulatory expert at the helm, Arletta Pharma is betting on its dual-action therapy, Lybrido, to transform the underserved FSIAD market.

Defiance ETFs launches Europe's first memory-focused fund as analysts predict prices could soar 130%, reshaping the entire global technology supply chain.